Anebulo Pharmaceuticals CEO Simon Allen receives $2.1M in 2022
Anebulo Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: October 17, 2022
Anebulo Pharmaceuticals reported fiscal year 2022 executive compensation information on October 17, 2022.
In 2022, four executives at Anebulo Pharmaceuticals received on average a compensation package of $724K, a 503% increase compared to previous year.
Average pay of disclosed executives at Anebulo Pharmaceuticals
Simon Allen, Chief Executive Officer, received $2.1M in total. 91% of Allen's compensation, or $1.9M, was in option awards. Allen also received $188K in salary.
Kenneth C. Cundy, Chief Scientific Officer, received a compensation package of $490K. 92% of the compensation package, or $450K, was in option awards.
Rex Merchant, Chief Financial Officer, earned $275K in 2022, a 130% increase compared to previous year.
Daniel Schneeberger, Chief Executive Officer, received $8.8K in 2022, which decreases by 93% compared to 2021.
Anebulo Pharmaceuticals' fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on October 17, 2022.